Zdrowie i gospodarka · 30/07/2025

FDA Announces Fiscal Year 2026 Outsourcing Facility Fee Rates

The FDA has set the fiscal year 2026 rates for establishment and reinspection fees for outsourcing facilities that compound human drugs and register under the FD&C Act, with fees ranging from $6,829 to $20,726.